Objective To characterise the changing trends in the pharmacological management of SLE in the USA between 2007 and 2023 as ...

Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune ...

Study reveals that achieving low disease activity or remission in lupus patients with high disease activity reduces organ ...

Sana Biotechnology results from the phase 1 study using SC291 for the treatment of patients with SLE are expected in 2025.

ACR 2024 highlighted new guidelines for the screening, treatment, and management of lupus nephritis, stressing prompt kidney biopsy and timely treatment.

All Three Patients Treated in First Dose Cohort Administered Fludarabine-free Conditioning and Show Rapid, Deep, and ...

Among 1,029 lupus patients in high disease activity status (HDAS) followed for a median of 2.7 years, just 20.9% got to a ...